⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

CRL

Charles River Laboratories International, Inc.

Healthcare · Diagnostics & Research

345.37USD

+5.7100 (+1.68%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on CRL.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 345.37
P/E—
Dvd Ind Yld0.0%
P/B5.81
P/S4.1
Curr EV/T12M EBITDA49.9
Mkt Cap (USD)16.5B
Curr EV (USD)19.4B
2)

Per Share Data

EPS T12M-4.81
DPS—
Bk Val Per Sh59.50
Rev/Sh83.28
Cash/Sh4.02
Curr Shares Out47.7M
FCF/Sh7.72
3)

Cash Flow Analysis

P/CF28.3
Curr P/FCF44.5
CF/NI-2.4
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales14.6%
Eff Interest Rate3823.7%
4)

Growth Potential

Dil EPS 1Y Gr-1555.0%
Cap 1Y Gr-8.6%
BPS 1Y Gr-4.8%
R&D To Sales—
Retention Rate100.0%
Rev 1Y Gr-0.9%
FCF 1Y Gr3.4%
Assets 1Y Gr-5.2%
5)

Profitability

EBITDA0.4B
EBIT0.1B
Operating Margin2.3%
Pretax Margin7.6%
Net Margin-6.0%
ROA-3.2%
ROE-7.7%
ROC1.7%
Asset Turnover0.53
6)

Structure

Current Ratio1.35
Quick Ratio0.80
Debt/Assets21.7%
Debt/Com Eq57.5%
Net Debt/EBITDA3.71
Tot Debt/Capital36.5%
Gross Margin35.2%
EBIT/Int Exp0.8

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.